. . . . . . . "[It was recently approved by the FDA and EMA for use in combination with bortezomib and dexamethasone in patients with multiple myeloma who have received ?2 prior regimens, including bortezomib and an immunomodulatory drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:50+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .